Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

H3K27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours.

Authors:
Iben Lyskjaer Daniel Lindsay Roberto Tirabosco Christopher D Steele Patrick Lombard Anna-Christina Strobl Ana M Rocha Christopher Davies Hongtao Ye Elise Bekers Julia Ingruber Matt Lechner Fernanda Amary Nischalan Pillay Adrienne M Flanagan

J Pathol 2020 10 1;252(2):151-164. Epub 2020 Sep 1.

Research Department of Pathology, University College London, London, UK.

Diagnosing MPNST can be challenging, but genetic alterations recently identified in polycomb repressive complex 2 (PRC2) core component genes, EED and SUZ12, resulting in global loss of the histone 3 lysine 27 trimethylation (H3K27me3) epigenetic mark, represent drivers of malignancy and a valuable diagnostic tool. However, the reported loss of H3K27me3 expression ranges from 35% to 84%. We show that advances in molecular pathology now allow many MPNST mimics to be classified confidently. We confirm that MPNSTs harbouring mutations in PRC2 core components are associated with loss of H3K27me3 expression; whole-genome doubling was detected in 68%, and SSTR2 was amplified in 32% of MPNSTs. We demonstrate that loss of H3K27me3 expression occurs overall in 38% of MPNSTs, but is lost in 76% of histologically classical cases, whereas loss was detected in only 23% cases with heterologous elements and 14% where the diagnosis could not be provided on morphology alone. H3K27me3 loss is rarely seen in other high-grade sarcomas and was not found to be associated with an inferior outcome in MPNST. We show that DNA methylation profiling distinguishes MPNST from its histological mimics, was unrelated to anatomical site, and formed two main clusters, MeGroups 4 and 5. MeGroup 4 represents classical MPNSTs lacking H3K27me3 expression in the majority of cases, whereas MeGroup 5 comprises MPNSTs exhibiting non-classical histology and expressing H3K27me3 and cluster with undifferentiated sarcomas. The two MeGroups are distinguished by differentially methylated PRC2-associated genes, the majority of which are hypermethylated in the promoter regions in MeGroup 4, indicating that the PRC2 target genes are not expressed in these tumours. The methylation profiles of MPNSTs with retention of H3K27me3 in MeGroups 4 and 5 are independent of mutations in PRC2 core components and the driver(s) in these groups remain to be identified. Our results open new avenues of investigation. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.5507DOI Listing
October 2020

Publication Analysis

Top Keywords

h3k27me3 expression
20
loss h3k27me3
12
prc2 core
12
h3k27me3
9
core components
8
mutations prc2
8
loss
6
mpnsts
6
expressed tumours
4
detected 23%
4
23% cases
4
loss detected
4
tumours methylation
4
lost 76%
4
76% histologically
4
histologically classical
4
classical cases
4
cases loss
4
heterologous elements
4
diagnosis provided
4

Altmetric Statistics


Show full details
5 Total Shares
5 Tweets
5 Citations

Similar Publications

SUMO2, a small ubiquitin-like modifier, is essential for development of murine preimplantation embryos.

Authors:
Ying Yang Yingbing Zhang Peipei Qiao Bin Yang Huiqun Jia Yong Zhang Jun Zhang Jianmin Su

Theriogenology 2021 Feb 27;166:29-37. Epub 2021 Feb 27.

College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi Province, 712100, PR China. Electronic address:

Small ubiquitin-like modifier 2 (SUMO2) is a small protein that modulates the stability and activity of other proteins. Although a variety of activities have been attributed to SUMO2, its function in preimplantation embryos is still obscure. We first explored the expression of SUMO2 protein in early embryos, and showed that compared with the 2-cell stage, the expression was increased at first, peaked at the 8-cell stage, and then dramatically decreased. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

JASMONATE-ZIM DOMAIN proteins engage Polycomb chromatin modifiers to modulate Jasmonate signaling in Arabidopsis.

Authors:
Zicong Li Xiao Luo Yang Ou Huijun Jiao Li Peng Xing Fu Alberto P Macho Renyi Liu Yuehui He

Mol Plant 2021 Mar 3. Epub 2021 Mar 3.

Shanghai Center for Plant Stress Biology, Chinese Academy of Sciences Center for Excellence in Molecular Plant Sciences, Shanghai 201602, China; Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore; Peking University Institute of Advanced Agricultural Sciences, Weifang, Shandong, 261000, China; State Key Laboratory of Protein and Plant Gene Research, Peking-Tsinghua Center for Life Sciences, School of Advanced Agriculture Sciences, Peking University, Beijing, 100871, China. Electronic address:

Jasmonate (JA) regulates various aspects of plant growth and development and stress responses, with prominent roles in male reproductive development and defenses against herbivores and necrotrophic pathogens. JASMONATE-ZIM DOMAIN (JAZ) proteins are key regulators in the JA signaling pathway and function to repress the expression of JA-responsive genes. Here, we show that JAZ proteins directly interact with several chromatin-associated Polycomb proteins to mediate repressive chromatin modifications at part of JA-responsive genes and thus their transcriptional repression in Arabidopsis. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Epigenetic regulation of p62/SQSTM1 overcomes the radioresistance of head and neck cancer cells via autophagy-dependent senescence induction.

Authors:
Myungjin Lee Hae Yun Nam Hee-Bum Kang Won Hyeok Lee Geun-Hee Lee Gi-Jun Sung Myung Woul Han Kyung-Ja Cho Eun-Ju Chang Kyung-Chul Choi Seong Who Kim Sang Yoon Kim

Cell Death Dis 2021 Mar 5;12(3):250. Epub 2021 Mar 5.

Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Tumors are composed of subpopulations of cancer cells with functionally distinct features. Intratumoral heterogeneity limits the therapeutic effectiveness of cancer drugs. To address this issue, it is important to understand the regulatory mechanisms driving a subclonal variety within a therapy-resistant tumor. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

SDG711 Is Involved in Rice Seed Development through Regulation of Starch Metabolism Gene Expression in Coordination with Other Histone Modifications.

Authors:
Xiaoyun Liu Junling Luo Tiantian Li Huilan Yang Ping Wang Lufang Su Yu Zheng Chun Bao Chao Zhou

Rice (N Y) 2021 Mar 5;14(1):25. Epub 2021 Mar 5.

Key Laboratory of Three Gorges Regional Plant Genetics & Germplasm Enhancement (CTGU) /Biotechnology Research Center, China Three Gorges University, Yichang, 443002, China.

SDG711 is a histone H3K27me2/3 transmethylase in rice, a homolog of CLF in Arabidopsis, and plays key roles in regulating flowering time and panicle development. In this work, we investigated the role of SDG711 in rice seed development. Overexpression and downregulation of SDG711 lead to a decrease and increase in the expression level of genes related to starch accumulation, resulting in smaller seeds or even seed abortion. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Overexpression of EZH2/NSD2 Histone Methyltransferase Axis Predicts Poor Prognosis and Accelerates Tumor Progression in Triple-Negative Breast Cancer.

Authors:
Bo Gao Xiumin Liu Zhengjin Li Lixian Zhao Yun Pan

Front Oncol 2020 16;10:600514. Epub 2021 Feb 16.

Department of Pathology, First Affiliated Hospital of Dali University, Dali, China.

Two histone methyltransferases, enhancer of zeste homolog 2 (EZH2) and nuclear SET domain-containing 2 (NSD2), are aberrantly expressed in several types of human cancers. However, the regulatory relationship between EZH2 and NSD2 and their prognostic values in breast cancer (BC) have not been fully elucidated. In this study, we demonstrated that EZH2 and NSD2 were overexpressed in BC compared with benign lesions and normal tissues using tissue microarray, immunohistochemistry, and bioinformatic databases. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap